Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
CLIA Kit for Sulfatase 2 (SULF2)
HSULF-2; Extracellular sulfatase Sulf-2
- Product No.SCH107Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length2h, 40min
- Detection Range0.14-100ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.09ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 588
For more details, please contact local distributors! US$ 840 US$ 3780 US$ 7140 US$ 58800
Specificity
This assay has high sensitivity and excellent specificity for detection of Sulfatase 2 (SULF2).
No significant cross-reactivity or interference between Sulfatase 2 (SULF2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Sulfatase 2 (SULF2) and the recovery rates were calculated by comparing the measured value to the expected amount of Sulfatase 2 (SULF2) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 80-104 | 87 |
EDTA plasma(n=5) | 91-104 | 96 |
heparin plasma(n=5) | 78-89 | 82 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Sulfatase 2 (SULF2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Sulfatase 2 (SULF2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Sulfatase 2 (SULF2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 96-105% | 84-102% | 83-101% | 98-105% |
EDTA plasma(n=5) | 98-105% | 96-104% | 84-91% | 97-105% |
heparin plasma(n=5) | 83-99% | 83-97% | 89-97% | 83-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
Substrate A | 1×10mL | Substrate B | 1×2mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.
GIVEAWAYS
INCREMENT SERVICES
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of Kit
- CLIA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Streptavidin
- Fast blue Protein Stain solution
- Single-component Reagents of FLIA Kit
- Streptavidin-Agarose Beads
Magazine | Citations |
Journal of Applied Pharmaceutical Science | Cytotoxic effects of antiglypican-3 against HepG4 cell line Ebscohost: Source |
European Journal of Pharmacology | Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma Pubmed:25449037 |
Biomedicine & Pharmacotherapy | Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 and Pubmed:29669302 |
Experimental Dermatology | Antitumor activity of sulforaphane in mice model of skin cancer via blocking sulfatase‐2 Pubmed: 30315662 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPH107Hu01 | Recombinant Sulfatase 2 (SULF2) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAH107Hu01 | Polyclonal Antibody to Sulfatase 2 (SULF2) | WB; ICC/IF |
LAH107Hu81 | FITC-Linked Polyclonal Antibody to Sulfatase 2 (SULF2) | WB; IHC; ICC; IF. |
LAH107Hu71 | Biotin-Linked Polyclonal Antibody to Sulfatase 2 (SULF2) | WB; IHC; ICC. |
MAH107Hu21 | Monoclonal Antibody to Sulfatase 2 (SULF2) | WB; IHC; ICC; IP. |
SEH107Hu | ELISA Kit for Sulfatase 2 (SULF2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCH107Hu | CLIA Kit for Sulfatase 2 (SULF2) | Chemiluminescent immunoassay for Antigen Detection. |
LMH107Hu | Multiplex Assay Kit for Sulfatase 2 (SULF2) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |